CC
LH icon

Centiva Capital’s Labcorp LH Stock Holding History

Centiva Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,900
Closed -$774K – 2055
2026
Q1 		$774K Buy
+2,900
New +$785K 0.01% 671
2025
Q2 		– Sell
-5,159
Closed -$1.2M – 1839
2025
Q1 		$1.2M Buy
+5,159
New +$1.25M 0.04% 379
2024
Q4 		– Sell
-6,562
Closed -$1.47M – 2076
2024
Q3 		$1.47M Buy
+6,562
New +$1.44M 0.03% 618
2024
Q2 		– Sell
-8,464
Closed -$1.85M – 2313
2024
Q1 		$1.85M Buy
+8,464
New +$1.86M 0.05% 373
2023
Q1 		– Sell
-2,838
Closed -$574K – 1693
2022
Q4 		$574K Buy
2,838
+1,399
+97% +$273K 0.02% 730
2022
Q3 		$253K Sell
1,439
-904
-39% -$185K ﹤0.01% 1101
2022
Q2 		$472K Sell
2,343
-3,683
-61% -$785K 0.01% 944
2022
Q1 		$1.36M Buy
+6,026
New +$1.42M 0.03% 589
2021
Q1 		– Sell
-1,669
Closed -$292K – 1305
2020
Q4 		$292K Buy
+1,669
New +$288K 0.01% 659

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Centiva Capital's LH Position: Q2 2026 in Review

Centiva Capital sold out of Labcorp (LH) in Q2 2026, closing a stake of 2,900 shares — an estimated $774K sold.

Centiva Capital first reported a position in LH in Q4 2020 and held it in 9 quarters. The position peaked at $1.85M in Q1 2024. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Centiva Capital reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 2,900 Labcorp shares in Q2 2026, an estimated $774K.
  • Centiva Capital first reported a position in Labcorp in Q4 2020 and held it in 9 quarters.
  • Centiva Capital's Labcorp position peaked at $1.85M in Q1 2024.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.